CHYPF (Health Logic Interactive) ROA %: -200.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Logic Interactive ROA %?

Health Logic Interactive CHYPF ROA % is -200.00% as of Mar. 2026. The stock has 1 warning sign investors should review.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Health Logic Interactive's annualized Net Income for the quarter that ended in Mar. 2026 was $-0.02 Mil. Health Logic Interactive's average Total Assets over the quarter that ended in Mar. 2026 was $0.01 Mil. Therefore, Health Logic Interactive's annualized ROA % for the quarter that ended in Mar. 2026 was -200.00%.

The historical rank and industry rank for Health Logic Interactive's ROA % or its related term are showing as below:

CHYPF' s ROA % Range Over the Past 10 Years
Min: -861.49   Med: -299.41   Max: 1810.46
Current: -307.23

During the past 13 years, Health Logic Interactive's highest ROA % was 1810.46%. The lowest was -861.49%. And the median was -299.41%.

CHYPF's ROA % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.5 vs CHYPF: -307.23

Health Logic Interactive  (OTCPK:CHYPF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=-0.02/0.01
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.02 / 0)*(0 / 0.01)
=Net Margin %*Asset Turnover
=N/A %*0
=-200.00 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Health Logic Interactive ROA % Related Terms


Health Logic Interactive ROA % Historical Data

* Premium members only.

The historical data trend for Health Logic Interactive's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Logic Interactive ROA % Chart

Health Logic Interactive Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,810.90 -253.44 -189.22 1,261.90 -347.83

Health Logic Interactive Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -177.78 -387.10 -311.11 -444.44 -200.00

CHYPF vs ABT, SYK, MDT: ROA % Comparison

For the Medical Devices subindustry, Health Logic Interactive's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Logic Interactive ROA % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Health Logic Interactive's ROA % distribution charts can be found below:

* The bar in red indicates where Health Logic Interactive's ROA % falls into.



Health Logic Interactive ROA % Calculation

Health Logic Interactive's annualized ROA % for the fiscal year that ended in Dec. 2025 is calculated as:

ROA %=Net Income (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=-0.04/( (0.014+0.009)/ 2 )
=-0.04/0.0115
=-347.83 %

Health Logic Interactive's annualized ROA % for the quarter that ended in Mar. 2026 is calculated as:

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-0.02/( (0.009+0.011)/ 2 )
=-0.02/0.01
=-200.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -200.00% mean?
Health Logic Interactive (CHYPF) has a ROA % of -200.00% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Health Logic Interactive and its competitors.
Is Health Logic Interactive's ROA % too high?
Health Logic Interactive's current ROA % is -200.00%.
How does Health Logic Interactive's ROA % compare to ABT and SYK?
Health Logic Interactive's ROA % of -200.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROA % is 0.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.50, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Health Logic Interactive and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Logic Interactive's current ROA % is -200.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Logic Interactive stock overvalued right now?
Health Logic Interactive (CHYPF) has a current ROA % of -200.00%. The current ROA % is -200.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Health Logic Interactive (CHYPF), the current ROA % is -200.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Logic Interactive Business Description

Address 350 - 7th Avenue SW, Suite 1400, Calgary, AB, CAN, T2P 3N9
Health Logic Interactive Inc is a Canada-based company that intends to develop consumer-focused healthcare technologies that addresses areas of unmet needs. The company, through its subsidiary, intends to advance and commercialize novel medical devices for Chronic Kidney Disease.